GLUE
NASDAQ
$17.74
Monte Rosa Therapeutics Inc (GLUE)
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new precision small molecule drugs that employ the body's natural mechanisms to selectively break down therapeutically relevant proteins. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $32.33 (+82.24%)
Market Cap
$1.62B
Free Cash Flow Yield
-1.22%
Beta (5Y)
1.35
Price Chart
Valuation
Market Cap$1.62B
Forward P/E10.02
P/S38.14
P/B3.14
Profitability
Total Revenue (TTM)$40M
Gross Profit (TTM)-$102M
EBITDA-$131M
Operating Margin-1188%
EPS-$1.75
Financial Health
Free Cash Flow Yield-1.22%
Growth & Risk
Beta (5Y)1.35
Sharpe Ratio1.94